Approval · Notice of Compliance 1301 · 2000
PERGONAL: Notice of Compliance 1301
Issued July 27, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1301
- Date
- July 27, 2000
- Company
- Serono Canada Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Gonadotropin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PERGONAL | 00254916 | Cancelled Post Market |
Medicinal ingredients
- FOLLICLE STIMULATING HORMONE (FSH) 75 UNIT per AMP
- RECOMBINANT HUMAN LUTEINIZING HORMONE 75 UNIT per AMP